RNAC icon

Cartesian Therapeutics
RNAC

Overview Fund Activity

48 hedge funds and large institutions have $235M invested in Cartesian Therapeutics in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 27 increasing their positions, 3 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
+2
Holders Change %
+4.35%
% of All Funds
1.2%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
9
Increased
27
Reduced
3
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VC
Vivo Capital
California
$22.2M
2
GPP
Great Point Partners
Connecticut
$18.6M
3
PA
Perceptive Advisors
New York
$15.8M
4
BlackRock
BlackRock
New York
$9.94M
5
Vanguard Group
Vanguard Group
Pennsylvania
$4.32M

Top Sellers

1
FP
Flagship Pioneering
Massachusetts
$0
2
UBS Group
UBS Group
Switzerland
$44K
3
Goldman Sachs
Goldman Sachs
New York
$0
4
HP
Hikari Power
Japan
$0
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Susquehanna International Group
51
Susquehanna International Group
Pennsylvania
– -$192K -447 Closed
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
– -$5K -11 Closed
CAG
53
Crestwood Advisors Group
Massachusetts
– -$4K -11 Closed
1 2
3